U.S. Water Utilities Stock News

Shake Shack (SHAK) has grabbed fresh attention after CEO Rob Lynch laid out upbeat 2026 goals, pairing a plan to dramatically expand its U.S. footprint with ongoing gains in customer traffic and margins. See our latest analysis for Shake Shack. That upbeat roadmap is landing after a volatile stretch. The latest $83.65 share price sits well below its year to date share price return of negative 37.23 percent, yet it stands alongside a three year total shareholder return of 80.12 percent. This...

Wix.com (WIX) shares have slid sharply over the past month and the past 3 months, even as the business continues to grow double digits in revenue and earnings, raising a fresh valuation question for investors. See our latest analysis for Wix.com. At a share price of $97.78, Wix.com has seen its 30 day share price return tumble nearly 22 percent and its year to date share price return fall sharply. However, the three year total shareholder return remains positive, signaling that recent...

Recent move in Spectrum Brands Holdings stock Spectrum Brands Holdings (SPB) has quietly climbed about 8% over the past week and 16% in the past 3 months, even though the share price is still down sharply year to date. See our latest analysis for Spectrum Brands Holdings. That recent 8% 7 day share price return and 16% 3 month share price return look more like a relief rally than a full trend change, given the year to date share price return is still deeply negative and the longer term total...

MSCI (MSCI) is back in the spotlight as it weighs stricter rules for digital assets in its indexes, including the potential exclusion of companies whose balance sheets rely heavily on cryptocurrencies and digital asset treasuries. See our latest analysis for MSCI. Those tougher digital asset rules land at an interesting time for the stock. A recent 7 day share price return of 3.09 percent has helped to steady what has otherwise been a weak year to date share price return of negative 7.3...

Earlier in December 2025, Pharvaris reported pivotal Phase 3 RAPIDe-3 data for its oral deucrictibant capsule in hereditary angioedema (HAE) and confirmed plans to begin global marketing authorization filings, including a U.S. FDA New Drug Application, starting in the first half of 2026. An especially important angle for investors is that, if the ongoing CHAPTER-3 trial is successful, deucrictibant could become the first oral therapy designed to address both on-demand and prophylactic...

If you are wondering whether U.S. Bancorp at around $53.71 is still worth buying after its recent run, you are not alone. This piece is going to unpack what the current price really implies about value. The stock has climbed about 4.5% over the last week and 14.0% in the past month, building on a 12.2% gain year to date and roughly 9.3% over the last year. This hints that the market is slowly warming back up to the name after a choppy few years. Recent headlines have focused on the health of...

If you are wondering whether Arm Holdings is attractively priced today or whether the excitement is already fully reflected in the share price, you are in the right place to unpack what the market might be missing. After a sharp rally earlier in the year, the stock has recently cooled off, with the price down around 11% over the last week and month, and about 3% lower year to date, leaving it roughly 14.2% below where it was a year ago. These swings come as investors digest Arm’s push deeper...

Market context for Eli Lilly Eli Lilly (LLY) has been quietly grinding higher, with the stock up about 4% over the past month and nearly 39% in the past 3 months, far outpacing the broader market. See our latest analysis for Eli Lilly. That move fits into a powerful run, with a roughly 36.5% year to date share price return and a 37.4% one year total shareholder return. This suggests momentum is still very much building rather than fading. If Lilly’s surge has you rethinking healthcare...

Murphy USA recently appointed Michael G. Kulp, Founder and CEO of KBP Brands, to its board as an independent Class I director, assigning him to the Audit and Executive Compensation Committees with a term running through the 2026 annual meeting. Kulp’s experience scaling more than 1,200 fast-food restaurant locations through over 95 multi-unit acquisitions may give Murphy USA fresh operational and M&A insights that are highly relevant to a large, efficiency-focused fuel and convenience...

CRA International (CRAI) has quietly outperformed the broader market over the past month, gaining about 10%, even as its past year has been roughly flat. That combination of steady fundamentals and uneven sentiment may create an interesting point for investors to take a closer look. See our latest analysis for CRA International. With the share price now around $199.19 and a 30 day share price return of just over 10%, the near term momentum stands in contrast to a slightly negative 1 year...

Wondering if YETI Holdings is finally at a buyable price, or if the market is still clinging to the brand hype? Let us unpack what the numbers are actually saying about value here. After a choppy few years, the stock has crept higher, up 1.0% over the past week and 16.2% over the last month. That brings its year-to-date gain to 15.6% but leaves the 1-year return almost flat at 0.3%, and the 5-year return still down about 40.0% from earlier highs. Recently, YETI has stayed in the conversation...

Earlier in December 2025, Marqeta, Inc. announced that its Board had authorized a share repurchase program of up to US$100 million of its Class A common stock, with no set expiration date and execution aligned to its capital allocation priorities. This buyback initiative highlights management’s confidence in Marqeta’s underlying business and signals an intention to return excess capital while potentially reducing share count over time. We’ll now examine how Marqeta’s newly announced...

Strategy (MSTR) has quietly slid over the past few months, with the stock down about 19% this month and more than 50% over the past 3 months, despite solid net income growth. See our latest analysis for Strategy. The recent slide is a sharp contrast to Strategy’s multiyear run, with the share price now at $162.08 and short term share price momentum clearly fading, even as longer term total shareholder returns remain impressive. If this shift in sentiment has you reassessing opportunities in...

If you are wondering whether Solstice Advanced Materials is still flying under the radar or already priced for perfection, you are not alone. This stock has quietly moved onto many watchlists. In the last week the share price has climbed 4.5%, and over the past 30 days it is up a solid 12.0%, even though year to date it is only slightly ahead at 0.8%. Much of that recent momentum has followed upbeat commentary around demand for next generation battery materials and new supply agreements with...

Wondering if UiPath at around $16 a share is quietly setting up a bargain, or just another hype name in automation? Let's cut through the noise and focus on what the numbers are really saying about its value. The stock has been choppy lately, sliding about 16.2% over the last week, but still up roughly 15.2% over the past month and 25.0% year to date, which tells you sentiment is shifting fast. Over the last year it is still sitting on a 14.9% gain, and roughly 29.5% higher over three years,...

Willis Towers Watson (WTW) has been quietly grinding higher, with the stock up around 7% this year and roughly flat over the past 3 months, despite mixed profit and revenue growth trends. See our latest analysis for Willis Towers Watson. At around $330.77 per share, Willis Towers Watson’s steady year to date share price return of about 7% and robust five year total shareholder return near 70% suggest momentum is gradually building as investors grow more comfortable with its mixed growth...

QUALCOMM (QCOM) just logged its ninth straight quarter of topping both revenue and EPS expectations, and that consistency is exactly why investors are paying closer attention to the stock right now. See our latest analysis for QUALCOMM. The market seems to be catching on, with QUALCOMM’s share price up 16.68% on a year to date basis and its 3 year total shareholder return of 70.40% reflecting how investors have been rewarding its steady execution, ongoing acquisitions in AI and data center,...

Crown Castle (CCI) has quietly drifted lower over the past month, and that slide is prompting fresh questions about what investors are really paying for in this tower and fiber landlord. See our latest analysis for Crown Castle. That recent 4.4% 3 month share price pullback comes on top of a 1 year total shareholder return of negative 1.7% and a bruising negative 20.8% over three years. This suggests momentum is still fading as investors reassess tower growth and balance sheet risk. If Crown...

Texas Instruments (TXN) has been drifting slightly lower this week, but the bigger story sits beneath the share price. Even with a modest pullback, the chipmaker’s multiyear returns still outpace the broader market. See our latest analysis for Texas Instruments. The recent pullback leaves Texas Instruments’ share price at $177.99, after an 11.71% 1 month share price return that has eased off and a more muted 1 year total shareholder return of negative 3 percent. This suggests momentum is...

Mach Natural Resources (MNR) has been sliding, with shares down around 14% over the past 3 months and more than 30% this year, even as revenue and net income continue to grow. See our latest analysis for Mach Natural Resources. At the current share price of $11.71, the stock’s year to date share price return of negative 31.40 percent contrasts with a milder 1 year total shareholder return of negative 12.46 percent, suggesting sentiment has cooled even as fundamentals improve. If Mach’s recent...

In recent months, Nutanix completed a US$288.6 million share repurchase program covering 4,861,000 shares and announced new Nutanix Cloud Platform capabilities to support secure, compliant sovereign and distributed cloud deployments across major hyperscalers. The combination of capital returns via buybacks and expanded multi-cloud and AI-focused platform features underscores how Nutanix is trying to strengthen both shareholder value and its role in complex enterprise cloud...

Tradeweb Markets (TW) has quietly slid about 21% over the past year, even as its electronic trading platform continues to generate solid revenue and profit growth. This has created an interesting gap between share performance and business momentum. See our latest analysis for Tradeweb Markets. Despite the latest share price of $104.2 and a recent stretch of weaker momentum, including a double digit 3 month share price pullback, Tradeweb still boasts a strong three year total shareholder...

In November 2025, Robbins Geller Rudman & Dowd LLP began investigating Ardent Health, Inc. for potential U.S. securities law violations after the company missed third-quarter earnings due to heightened payor denials, adverse prior-period claim developments, and an accounting estimate change that brought forward revenue reserves. This combination of legal scrutiny and earlier revenue recognition raised fresh questions about Ardent Health’s disclosure practices, earnings quality, and the...

If you are wondering whether SLB is quietly becoming a value opportunity while the market is distracted, this article will walk you through whether the current price really lines up with the business behind the ticker. After a choppy few years, SLB has inched up 1.7% over the last week and 5.3% over the last month, while still only 0.6% higher over the past year despite being up 98.8% over five years. Recent headlines have focused on SLB doubling down on digital and low carbon technologies,...